President Research / 3M / Prostate Centre Dr. Martin Gleave Tumour / Canadian National Tumour Bank Network / Xillix Technologies / BCCA Dr. Stephen Lam Prostate / General Motors / Terry Fox Laboratory / Tissue Bank / Innovation (Federal) (excludes new CRC funds) BC Knowledge Development Fund / /
Country
Canada / United Kingdom / United States / /
Currency
USD / /
Event
Patent Issuance / Patent Filing / FDA Phase / /
Facility
University of British Columbia / Other The Prostate Centre / BC Children’s Hospital / National Cancer Institute of Canada / The Prostate Centre / Vancouver General Hospital / UBC Campus / Simon Fraser University / Vancouver General Hospital/ Vancouver Coastal Health Research Institute / University of Victoria / Michael Smith Genome Sciences Centre / Array Facility / Laboratory Medicine / Vancouver Coastal Health Research Institute / BC Women’s Hospital / Gene Array Facility / Deeley Research Centre / /
IndustryTerm
latter using lipid-based systems / cancer therapy / cancer detection technologies / large pharmaceutical / established networks / cancer therapeutics / diagnostics using technologies / chemotherapy services / companies using technology / imaging / therapeutic protocols / bank / treatment of cancer / Cancer Care / or marketing new products / manufacturing / anti-cancer product / evidence-based therapeutic protocols / cancer prevention / patient management protocols / early stage products / lipid-based drug delivery technology / pharmaceutical / treatment services / sociobehavioural and other services / treatment of early / noninvasive cancer / Cancer Prevention Program / drug delivery technologies / throughput microarray technology / healthcare planners / /
MarketIndex
Top 40 / /
MedicalCondition
prominent cancer / prostate cancers / translational cancer / prostate cancer / breast cancer / Leukemia / BCCA Dr. Stephen Lam Prostate cancer / Cancer / different cancers / rare cancer / pre-invasive lung cancer / genomic derived cancer / breast and ovarian cancer / diseases / non-Hodgkin lymphoma / skin cancers / lymphoma / exclusive population-based cancer / renowned cancer / colorectal cancers / Targeted Diseases / breast and ovarian cancers ( emsy ) / each cancer / additional community cancer / lung cancers / cancers / breast cancers / troduction Cancer / disease / BCCA Dr. Doug Horsman Lung cancer / important world-class cancer / B.C.’s Cancer Researchers B.C / single disease / tumour / lymphoma research team / lung cancer / noninvasive cancer / multidrug resistant cancer / B.C.’s cancer / specific cancer / B.C. cancer / chronic myeloid leukemia / Addresses cancer / Anemia / population-based cancer / Cancer Site/Type / /
MedicalTreatment
surgery / cancer therapy / radiation therapy / chemoprevention / chemotherapy / cancer therapeutics / /
MusicGroup
B.C. / /
NaturalFeature
Fraser Valley / Vancouver Island / /
Organization
Cancer Imaging Department / Centre for Molecular Medicine and Therapeutics / US government / Canadian Government / Clinical Trials Unit / Senior Scientists Department / UBC Faculty of Medicine / Centre for Translational and Applied Genomics / Health Centre / BC Cancer Agency / Centre for Integrated Genomics / Children and Women’s Health Centre / Cancer Research U.S. Government / The Children and Women’s Health Centre of BC* / Division of Urology / University of Victoria / Cancer Research Centre / Vancouver Coastal Health Research Institute / Royal Society of Canada / American Cancer Society / BC Centre for Disease Control / Deeley Research Centre / BC Knowledge Development Fund / National Institute of Health / Cancer Research Facilities Services Centre for Drug Research and Development / Genome BC Proteomics Centre / UK’s Medical Research Council / Canadian Cancer Society / BC Women’s Hospital / Michael Smith Genome Sciences Centre / Medical Research Council / BCCA New Phase I/II Unit / Genetic Pathology Evaluation Centre / Vancouver General Hospital / UBC Bioinformatics Centre / BC Children’s Hospital / Sociobehavioural Research Centre / Cancer Research and Clinical Centres Institution Description BCCA* BC Cancer Research Centre / National Cancer Institute of Canada / Department of Defense / Health Canadian Fund for Innovation / Department of Surgery / Provincial Health Services Authority / University of British Columbia / Simon Fraser University / /
Person
Centre / Dean / Richard J. Finley / William E. Rawls / Genetic Pathology / Neil Branda / Miriam Rosin / John Schrader / David Huntsman / Robert L. Noble / Clayton Smith / Peter Watson / Kinesiology / Chris Overall / Marco Marra / Sam Aparicio / Stephen Jones / Martin Gleave / Gene Array / /
Position
Director of Basic Science Research / Professor and Assistant / Head / Director / Clinical and Translational Research / founder and chief scientific officer / Gairdner Foundation International Award Calum MacAuley Head / Professor / Chair of the Lung Tumour Group / Biorepository Head / Associate Professor / Investigator / Researcher Research Focus / Co-director / Scientist / BC Leadership Chair / Professor / Medicine / Senior Staff Scientist / Director / Colleen Nelson Head / Director / Array Facility / Genome BC; Associate Professor / /
Product
Herceptin / Gleevec / Rituxan / Tarceva / BC / /
ProvinceOrState
British Columbia / Victoria / /
PublishedMedium
Cancer Research / /
Technology
radiation / proteomics / stem cells / cancer detection technologies / functional genomics / drug delivery / Drug Discovery / DNA Chip / gene expression / chemotherapy / treating cancer / genomics / lipid-based drug delivery technology / patient management protocols / bioinformatics / evidence-based therapeutic protocols / Hybridization / high throughput microarray technology / diagnostics using technologies / pharmacokinetics / drug delivery technologies / 15 companies using technology / drug development / /
Oncology Asset Map Activities, Strengths, and Opportunities